Ovarian Cancer Responds To Aspirin Derivative With Chemo

Armen Hareyan's picture

Treatment of Ovarian Cancer

A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy.


The study appears online in the Proceedings of the National Academy of Sciences.

As a first course of treatment, ovarian cancer typically is treated with surgery followed by a regimen of the chemotherapy drug cisplatin. However, cisplatin is not an effective treatment when the ovarian cancer inevitably returns, says Periannan Kuppusamy, a professor of internal medicine at the Ohio State University Comprehensive Cancer Center

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.